Cite

APA Citation

    de Kouchkovsky, I., Zhang, L., Philip, E. J., Wright, F., Kim, D. M., Natesan, D., Kwon, D., Ho, H., Ho, S., Chan, E., Porten, S. P., Wong, A. C., Desai, A., Huang, F. W., Chou, J., Oh, D. Y., Pruthi, R. S., Fong, L., Small, E. J., Friedlander, T. W., & Koshkin, V. (2021). tERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. Journal for immunotherapy of cancer, 9(5), . http://access.bl.uk/ark:/81055/vdc_100130163597.0x00000f
  
Back to record